Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 19/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 9/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.43 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.43 |
| ▸ | GSK3A | P49840 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1831443 | 0.97 | GSK3B (0.42) | GSK3BCYP2D6CYP1A2CSNK1A1GSK3A | |
| SCHEMBL1833225 | 0.87 | GSK3B (0.46) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL1834385 | 0.83 | GSK3B (0.45) | GSK3BCYP2D6CYP1A2 | |
| Bromide SCHEMBL1831381 | 0.82 | GSK3B (0.45) | GSK3BCYP2D6 | |
| SCHEMBL1833092 | 0.80 | GSK3B (0.47) | GSK3BCYP2D6 | |
| SCHEMBL1833870 | 0.79 | GSK3B (0.40) | GSK3BCYP2D6CYP1A2CSNK1A1GSK3A | |
| SCHEMBL1834240 | 0.78 | GSK3B (0.41) | GSK3BCYP2D6 | |
| SCHEMBL1831352 | 0.78 | GSK3B (0.41) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL1975075 | 0.78 | GSK3B (0.46) | GSK3BCYP2D6CYP1A2CSNK1A1GSK3A | |
| SCHEMBL1840230 | 0.78 | GSK3B (0.45) | GSK3BCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2011525908-A | — | — | 2011-09-29 | — | — | JP | claimed |
| EP-2321315-A2 | SUBSTITUTED ALKYL PYRIMIDIN-4-ONE DERIVATIVES | Mitsubishi Tanabe Pharma Corporation (JP) | 2011-05-18 | — | — | EP | claimed |
| WO-2009156864-A2 | SUBSTITUTED ALKYL PYRIMIDIN-4-ONE DERIVATIVES | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-12-30 | — | — | WO | claimed |